Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioNxt Solutions Inc C.BNXT

Alternate Symbol(s):  BNXTF

Healthcare
BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active... see more

Recent & Breaking News (CSE:BNXT)

XPhyto Signs German Distribution, Storage and Logistics Agreement for 25-Minute COVID-19 PCR Test

Featured Submission April 22, 2021

XPhyto Signs German Distribution, Storage and Logistics Agreement for 25-Minute COVID-19 PCR Test

Accesswire April 21, 2021

XPhyto adds Top-Level Executive Talent to its Global Operations

Accesswire April 20, 2021

XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Recent European Approval of 25-Minute COVID-19 PCR Test

GlobeNewswire March 29, 2021

XPhyto announces European Approval for 25 Minute COVID-19 PCR Test

Accesswire March 18, 2021

InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp.

GlobeNewswire March 12, 2021

XPhyto Partner Receives ISO Certification for 25-Minute COVID-19 RT-PCR Test

Accesswire March 10, 2021

XPhyto Completes Corporate Rebranding and Launches New Website

Accesswire March 4, 2021

With Psilocybin, Significant Progress is Being Made with Substance Use Disorders

Livemoney March 2, 2021

XPhyto Provides Updated Comments on Promotional and Marketing Activity

Accesswire February 26, 2021

XPhyto Places First Order for 25-Minute Covid-19 RT-PCR Tests

Accesswire February 24, 2021

XPhyto Builds Commercial Team to Launch 25-Minute Covid-19 RT-PCR Test

Accesswire February 22, 2021

XPhyto Reports Vektor Pharma GMBH Lawsuit

Accesswire February 19, 2021

XPhyto European CE-IVD Application for 25-Minute COVID-19 RT-PCR Test

Accesswire February 16, 2021

XPhyto Adds Mescaline Production to Psychedelic Medicine Programs

Accesswire February 10, 2021

XPhyto Announces Psychedelic Pharmaceutical Production Agreement

Accesswire February 3, 2021

XPhyto Announces Drug Formulation Strategy and 2021 Milestones Innovation to Impact

Accesswire January 28, 2021

XPhyto Provides Comments on Promotional and Marketing Activity

Accesswire January 22, 2021

XPhyto Announces Business Strategy and Milestones For 2021 Innovation to Impact

Accesswire January 18, 2021

XPhyto Therapeutics Closes Fully Subscribed Private Placement

Accesswire January 15, 2021